Form 4: Quest Diagnostics CFO Sells Shares for Tax Obligations

Quest Diagnostics' Executive Vice President and CFO, Sam Samad, sold 869 shares of common stock to cover tax liabilities from restricted share unit vesting.

Summary

• Sam Samad, Executive Vice President & CFO of Quest Diagnostics Inc. (DGX), reported a transaction involving the company's common stock.
• The transaction, dated March 2, 2026, was a disposition of 869 shares of common stock.
• The shares were sold at a price of $204.86 per share.
• This sale was conducted to satisfy tax obligations arising from the vesting of a previous grant of restricted share units.
• Following this transaction, Sam Samad beneficially owns 27,041 shares of Quest Diagnostics common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale of shares is a non-discretionary transaction to cover tax obligations from RSU vesting, rather than a discretionary sale indicating a change in sentiment.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales to cover tax obligations upon restricted share unit (RSU) vesting are routine and generally not indicative of management's discretionary sentiment towards the company's future prospects. This is a common practice across various industries for executives receiving equity compensation.

Key Dates

Recommendation

This Form 4 filing reports a routine, non-discretionary sale of shares by an executive to cover tax obligations upon the vesting of restricted stock units. Such transactions are common and do not typically signal a change in the company's fundamentals or management's outlook, thus warranting a 'hold' recommendation based solely on this filing.

Keywords

Quest Diagnostics, DGX, Form 4, Insider Transaction, Stock Sale, CFO, Restricted Stock Units, Tax Obligations